Financials in USD. Standardized financial statements.
A compact view of how RBC Life Sciences, Inc. turns revenue into operating income and net income.
| Metric | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $25.77M | $24.37M | $28.27M | $25.47M | $25.16M | $28.45M | $28.16M | $24.92M | $30.41M | $27.03M |
| Revenue Growth? | +5.8% | -13.8% | +11.0% | +1.2% | -11.6% | +1.0% | +13.0% | -18.0% | +12.5% | 0.0% |
| Cost of Revenue? | $12.16M | $10.90M | $12.63M | $13.46M | $12.53M | $14.13M | $14.47M | $12.12M | $14.91M | $12.13M |
| Gross Profit? | $13.61M | $13.46M | $15.64M | $12.01M | $12.63M | $14.32M | $13.69M | $12.80M | $15.49M | $14.90M |
| Gross Margin? | +52.8% | +55.2% | +55.3% | +47.2% | +50.2% | +50.3% | +48.6% | +51.4% | +51.0% | +55.1% |
| Operating Expenses? | $14.28M | $15.97M | $16.26M | $12.64M | $13.10M | $14.39M | $12.64M | $12.96M | $12.64M | $12.00M |
| Operating Income? | -$666,283 | -$2.51M | -$625,266 | -$624,624 | -$463,593 | -$70,885 | $1.04M | -$159,617 | $2.85M | $2.90M |
| EBITDA? | -$251,507 | -$302,450 | -$45,366 | -$36,337 | $121,144 | $435,698 | $1.58M | $295,986 | $3.23M | $3.26M |
| Income Before Tax | -$666,283 | -$846,104 | -$720,985 | -$736,241 | -$589,926 | -$210,840 | $891,207 | -$323,853 | $2.68M | $2.69M |
| Income Tax Expense | $90,001 | -$104,265 | -$118,174 | -$236,236 | -$228,490 | -$139,346 | $333,461 | $11,000 | $1.06M | $996,500 |
| Net Income? | -$756,284 | -$741,839 | -$602,811 | -$500,005 | -$361,436 | -$71,494 | $557,746 | -$334,853 | $1.62M | $1.69M |
| EPS? | $-0.34 | $-0.34 | $-0.27 | $-0.23 | $-0.16 | $-0.03 | $0.30 | $-0.15 | $0.80 | $0.80 |
| Diluted EPS? | $-0.34 | $-0.34 | $-0.27 | $-0.23 | $-0.16 | $-0.03 | $0.20 | $-0.15 | $0.70 | $0.80 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality